|
|
||||||||
The Annals of Thoracic Surgery, Vol 35, 516-524, Copyright © 1983 by The Society of Thoracic Surgeons
AJ Roberts, SM Spies, PR Lichtenthal, JM Moran, JH Sanders and LL Michaelis
Strict electrocardiographic, enzymatic, scintigraphic, and hemodynamic
criteria for perioperative myocardial infarction (MI) were defined and
related to serial assessments of left ventricular performance during rest
and exercise in patients seen early and late after coronary artery bypass
graft operation. Global left ventricular performance was determined by
radionuclide ventriculography from which changes in the pattern of serial
postoperative ejection fractions (EF) were obtained. Patients were divided
into two groups based on the presence or absence of perioperative MI, and
were matched in pairs on the basis of preoperative EF and extent as well as
location of coronary artery obstructions. The results indicate that neither
short- nor long-term depression in resting EF occurred subsequent to
perioperative MI. However, an exercise-related increase in EF eight months
postoperatively was depressed in patients who had perioperative MI compared
with those who did not. Patients with new Q waves and abnormal
postoperative elevation in serum levels of the myocardial isoenzyme of
creatine kinase (CK-MB) had a greater early decrease in EF compared with
patients without evidence of perioperative MI. However, seven days after
operation, the EF in both groups returned to preoperative levels. Patients
with abnormal technetium 99m-pyrophosphate scintigrams had changes in
perioperative EF similar to those in patients without MI. The presence of
low cardiac output syndrome immediately after operation was associated with
immediate and short-term decreases in EF, which were not seen in any of the
other patient subgroups.
ARTICLES
Changes in left ventricular performance related to perioperative myocardial infarction in coronary artery bypass graft surgery
This article has been cited by other articles:
![]() |
K. W. Mahaffey, M. T. Roe, R. Kilaru, J. H. Alexander, F. Van de Werf, R. M. Califf, M. L. Simoons, E. J. Topol, and R. A. Harrington Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials Eur. Heart J., February 2, 2007; 28(4): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramsay, S. Shernan, J. Fitch, P. Finnegan, T. Todaro, T. Filloon, and N. A. Nussmeier Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 300 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. K. Fitch, S. Rollins, L. Matis, B. Alford, S. Aranki, C. D. Collard, M. Dewar, J. Elefteriades, R. Hines, G. Kopf, et al. Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass Circulation, December 21, 1999; 100(25): 2499 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche, W. R. E. Jamieson, W. Flameng, M. K. Davies, and on behalf of the Multinational Acadesine Study Gro ACADESINE: A NEW DRUG THAT MAY IMPROVE MYOCARDIAL PROTECTION IN CORONARY ARTERY BYPASS GRAFTINGResults of the first international multicenter study J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1096 - 1106. [Abstract] [Full Text] |
||||
![]() |
M. R. Johnston, R. F. Minchen, and C. A. Dawson LUNG PERFUSION WITH CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE METASTATIC SARCOMA TO THE LUNG OR DIFFUSE BRONCHIOLOALVEOLAR CARCINOMA J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 368 - 373. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |